Advertisement

Environmental Chemistry Letters

, Volume 14, Issue 4, pp 455–465 | Cite as

Unexpected removal of the most neutral cationic pharmaceutical in river waters

  • Alan D. Tappin
  • J. Paul Loughnane
  • Alan J. McCarthy
  • Mark F. FitzsimonsEmail author
Original Paper

Abstract

Contamination of surface waters by pharmaceuticals is now widespread. There are few data on their environmental behaviour, particularly for those which are cationic at typical surface water pH. As the external surfaces of bacterio-plankton cells are hydrophilic with a net negative charge, it was anticipated that bacterio-plankton in surface-waters would preferentially remove the most extensively-ionised cation at a given pH. To test this hypothesis, the persistence of four, widely-used, cationic pharmaceuticals, chloroquine, quinine, fluphenazine and levamisole, was assessed in batch microcosms, comprising water and bacterio-plankton, to which pharmaceuticals were added and incubated for 21 days. Results show that levamisole concentrations decreased by 19 % in microcosms containing bacterio-plankton, and by 13 % in a parallel microcosm containing tripeptide as a priming agent. In contrast to levamisole, concentrations of quinine, chloroquine and fluphenazine were unchanged over 21 days in microcosms containing bacterio-plankton. At the river-water pH, levamisole is 28 % cationic, while quinine is 91–98 % cationic, chloroquine 99 % cationic and fluphenazine 72–86 % cationic. Thus, the most neutral compound, levamisole, showed greatest removal, contradicting the expected bacterio-plankton preference for ionised molecules. However, levamisole was the most hydrophilic molecule, based on its octanol–water solubility coefficient (K ow). Overall, the pattern of pharmaceutical behaviour within the incubations did not reflect the relative hydrophilicity of the pharmaceuticals predicted by the octanol–water distribution coefficient, D ow, suggesting that improved predictive power, with respect to modelling bioaccumulation, may be needed to develop robust environmental risk assessments for cationic pharmaceuticals.

Keywords

Levamisole Quinine Chloroquine Fluphenazine Persistence River 

Notes

Acknowledgments

This work was funded by the UK Natural Environment Research Council (Grant NE/E006302/1) and the Seale-Hayne Educational Trust of Plymouth University. We are grateful to Dr. Clare Redshaw (PU) for advice on the use of the Finnegan MAT LCQ mass spectrometer and Dr. Claire Williams (PU) for help with the inorganic nutrient analyses. The microcosm studies were undertaken in an ISO 9000:2001 accredited laboratory.

References

  1. Achan J, Talisuna A, Erhart A, Yeka A, Tibenderana J, Baliraine F, Rosenthal P, D’Alessandro U (2011) Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J 10:144–155CrossRefGoogle Scholar
  2. Ainsworth AM, Goulder R (1998) Microbial organic-nitrogen transformations along the Swale-Ouse river system, Northern England. Sci Total Environ 210(211):329–355CrossRefGoogle Scholar
  3. Alexander M (1999) Biodegradation and bioremediation, 2nd edn. Academic Press, LondonGoogle Scholar
  4. Arnold KE, Brown AR, Ankley GT, Sumpter JP (2014) Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems. Philos Trans R Soc Lond B Biol Sci 369:20130569CrossRefGoogle Scholar
  5. Barron AB, Søvik E, Cornish JL (2010) The roles of dopamine and related compounds in reward-seeking behavior across animal phyla. Front Behav Neurosci 4:163CrossRefGoogle Scholar
  6. Bengtsson MM, Wagner K, Burns NR, Herberg ER, Wanek W, Kaplan LA, Battin TJ (2014) No evidence of aquatic priming effects in hyporheic zone microcosms. Sci Rep 4:5187–5192CrossRefGoogle Scholar
  7. Benotti MJ, Brownawell BJ (2009) Microbial degradation of pharmaceuticals in estuarine and coastal seawater. Environ Pollut 157:994–1002CrossRefGoogle Scholar
  8. Bertol E, Mari F, Milia MG, Politi L, Furlanetto S, Karch SB (2011) Determination of aminorex in human urine samples by GC-MS after use of levamisole. J Pharm Biomed 55:1186–1189CrossRefGoogle Scholar
  9. Boxall AB, Rudd MA, Brooks BW et al (2012) Pharmaceuticals and personal care products in the environment: what are the big questions? Environ Health Perspect 120:1221–1229CrossRefGoogle Scholar
  10. Brodin T, Fick J, Jonsson M, Klaminder J (2013) Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science 339:814–815CrossRefGoogle Scholar
  11. Brodin T, Piovano S, Fick J, Klaminder J, Heynen M, Jonsson M (2014) Ecological effects of pharmaceuticals in aquatic systems—impacts through behavioural alterations. Philos Trans R Soc Lond B Biol Sci 369:20130580CrossRefGoogle Scholar
  12. Brooks BW, Covaci A, Barcelo D (2012) Pharmaceuticals and illicit drugs in aquatic systems. Science of the Total Environment, Virtual Special Issue. http://www.journals.elsevier.com/science-of-the-totalenvironment/virtual-special-issues/pharmaceuticals-and-illicit-drugs-in-aquatic-systems
  13. Capleton AC, Courage C, Rumsby P, Holmes P, Stutt E, Boxall ABA, Levy LS (2006) Prioritising veterinary medicines according to their potential indirect human exposure and toxicity profile. Toxicol Lett 163:213–223CrossRefGoogle Scholar
  14. Cizmas L, Sharma VK, Gray CM, McDonald TJ (2015) Pharmaceuticals and personal care products in waters: occurrence, toxicity, and risk. Environ Chem Lett 13:381–394CrossRefGoogle Scholar
  15. Dastidar SG, Chaudhury A, Annadurai S, Roy S, Mookerjee M, Chakrabarty AN (1995) In vitro and in vivo antimicrobial action of fluphenazine. J Chemother 7:201–206CrossRefGoogle Scholar
  16. ECETOC (2013) Environmental exposure assessment of ionisable organic compounds. Technical report No. 123. http://www.ecetoc.org/wp-content/uploads/2014/08/ECETOC-TR-123-Environmental-risk-assessment-of-ionisable-compounds.pdf. Accessed 18 Jul 2016
  17. Ellis LBM, Wackett LP (2012) Use of the University of Minnesota Biocatalysis/Biodegradation Database for study of microbial degradation. Microb Inform Exp 2:1–11CrossRefGoogle Scholar
  18. EU (2015) COMMISSION IMPLEMENTING DECISION (EU) 2015/495 of 20 March 2015 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council. http://eur-lex.europa.eu/legalcontent/EN/TXT/PDF/?uri=CELEX:32015D0495&from=EN. Accessed 18 Jul 2016
  19. Giacomini ACVV, Abreu MS, Giacomini LV, Siebel AM, Zimerman FF, Rambo CL, Mocelin R, Bonan CD, Piato AL, Barcellos LJG (2016) Fluoxetine and diazepam acutely modulate stress induced-behavior. Behav Brain Res 296:301–310CrossRefGoogle Scholar
  20. Gontikaki E, Thornton B, Huvenne VAI, Witte U (2013) Negative priming effect on organic matter mineralisation in NE Atlantic slope sediments. PLoS One 8:e67722CrossRefGoogle Scholar
  21. Griese JJ, Jakob RP, Schwarzinger S, Dobbek H (2006) Xenobiotic reductase A in the degradation of quinoline by Pseudomonas putida 86: function, structure and mechanism of 8-hydroxycoumarin reduction. J Mol Biol 361:140–152CrossRefGoogle Scholar
  22. Griffiths RI, Whiteley AS, O’Donnell AG, Bailey MJ (2000) Rapid method for co-extraction of DNA and RNA from natural environments for analysis of ribosomal DNA- abd RNA-based microbial community composition. Appl Environ Microbiol 66:5488–5491CrossRefGoogle Scholar
  23. Guenet B, Danger M, Abbadie L, Lacroix G (2010) Priming effect: bridging the gap between terrestrial and aquatic ecology. Ecology 91:2850–2861CrossRefGoogle Scholar
  24. Guenet B, Danger M, Harrault L, Allard B, Jauset-Alcala M, Bardoux G, Benest D, Abbadie L, Lacroix G (2014) Fast mineralization of land-born C in inland waters: first experimental evidences of aquatic priming effect. Hydrobiologia 721:35–44CrossRefGoogle Scholar
  25. Gulde R, Helbling DE, Scheidegger A, Fenner K (2014) pH-dependent biotransformation of ionizable organic micropollutants in activated sludge. Environ Sci Technol 48:13760–13768CrossRefGoogle Scholar
  26. Gulde R, Meier U, Schymanski EL, Kohler H-PE, Helbling DE, Derrer S, Rentsch D, Fenner K (2016) Systematic exploration of biotransformation reactions of amine-containing micropollutants in activated sludge. Environ Sci Technol 50:2908–2920CrossRefGoogle Scholar
  27. Hancock REW, Bell A (1988) Antibiotic uptake into gram-negative bacteria. Eur J Microbiol Infect Dis 7:713–720CrossRefGoogle Scholar
  28. Holmes RM, Aminot A, Kérouel R, Hooker BA, Peterson BJ (1999) A simple and precise method for measuring ammonium in marine and freshwater ecosystems. Can J Fish Aquat Sci 56:1801–1808CrossRefGoogle Scholar
  29. Hughes SR, Kay P, Brown LE (2013) Global synthesis and critical evaluation of pharmaceutical data sets collected from river systems. Environ Sci Technol 47:661–677CrossRefGoogle Scholar
  30. Hutchinson TH, Lyons BP, Thain JE, Law RJ (2013) Evaluating legacy contaminants and emerging chemicals in marine environments using adverse outcome pathways and biological effects-directed analysis. Mar Pollut Bull 74:517–525CrossRefGoogle Scholar
  31. IMS (2015) Global medicines use in 2020: outlook and implications. Institute for Healthcare Informatics, November 2015. http://www.imshealth.com/en/thought-leadership/ims-institute/reports/global-medicines-use-in-2020
  32. Jones OAH, Voulvoulis N, Lester JN (2002) Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36:5013–5022CrossRefGoogle Scholar
  33. Kah M, Brown CD (2008) Log D: lipophilicity for ionisable compounds. Chemosphere 72:1401–1408CrossRefGoogle Scholar
  34. Kulma A, Szopa J (2007) Catecholamines are active compounds in plants. Plant Sci 172:433–440CrossRefGoogle Scholar
  35. Kümmerer K (2008) Pharmaceuticals in the environment: sources, fate, effects and risks, 3rd edn. Springer, BerlinCrossRefGoogle Scholar
  36. LaLone CA, Berninger JP, Villeneuve DL, Ankley GT (2014) Leveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms. Philos Trans R Soc Lond B Biol Sci 369:20140022CrossRefGoogle Scholar
  37. Lane DJ (1991) 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M (eds) Nucleic acid techniques in bacterial systematics. Wiley, New YorkGoogle Scholar
  38. Lanusse CE, Alvaréz LI, Sallovitz JM, Mottier ML, Sanchez Bruni SF (2009) Antinematodal drugs. In: Riviere JE, Papich MG (eds) Veterinary pharmacology and therapeutics, 9th edn. Wiley-Blackwell, AmesGoogle Scholar
  39. Lautze J, Stander E, Drechsel P, da Silva AK, Keraita B (2014) Global experience in water reuse. In: CGIAR Research Program on Water, Land and Ecosystems (WLE). International Water Management Institute (IWMI), Colombo, Sri Lanka, p 31. Resource Recovery and Reuse Series 4. doi: 10.5337/2014.209
  40. Lees K, Fitzsimons M, Snape J, Tappin A, Comber S (2016) Pharmaceuticals in soils of lower income countries: physico-chemical fate and risks from wastewater irrigation. Environ Int 94:712–723CrossRefGoogle Scholar
  41. Lim M-H, Snyder SA, Sedlak DL (2008) Use of biodegradable dissolved organic carbon (BDOC) to assess the potential for transformation of wastewater-derived contaminants in surface waters. Water Res 42:2943–2952CrossRefGoogle Scholar
  42. Manallack DT, Prankerd RJ, Yuriev E, Oprea TI, Chalmers DK (2013) The significance of acid/base properties in drug discovery. Chem Soc Rev 42:485–496CrossRefGoogle Scholar
  43. McEvoy GK, Miller J, Litvak K (eds) (2004) American hospital (AHFS) drug information 2004. American Society of Health-System Pharmacists, BethesdaGoogle Scholar
  44. Mirghani RA, Ericsson O, Tybring G, Gustafsson LL, Bertilsson L (2003) Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man. Eur J Clin Pharmacol 59:23–28CrossRefGoogle Scholar
  45. Muyzer G, De Waal EC, Uitterlinden AG (1993) Profiling of complex microbial populations by denaturing gradient gel electrophoresis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 59:695–700Google Scholar
  46. Muyzer G, Teske A, Wirsen CO, Jannasch HW (1995) Phylogenic relationship of Thiomicrospira species and their identification in deep-sea hydrothermal vent samples by denaturing gradient gel electrophoresis of 16S rRNA fragments. Arch Microbiol 164:165–172CrossRefGoogle Scholar
  47. Nikaido H, Vaara M (1985) Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49:1–32Google Scholar
  48. Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S, Iqbal Chaudhry MJ, Arshad M, Mahmood S, Ali A, Ahmed Khan A (2004) Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427:630–633CrossRefGoogle Scholar
  49. OECD (2013) Guidance document on developing and assessing adverse outcome pathways. In: Environment, health and safety publications series on testing and assessment no. 184, Paris. http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2013)6&doclanguage=en
  50. Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ (2014) Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis 14:982–991CrossRefGoogle Scholar
  51. Projean D, Baune B, Farinotti R, Flinois JP, Beaune P, Taburet AM, Ducharme J (2003) In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Metab Dispos 31:748–754CrossRefGoogle Scholar
  52. Rendal C, Ole Kusk K, Trapp S (2011a) The effect of pH on the uptake and toxicity of the bivalent weak base chloroquine tested on Salix viminalis and Daphnia magna. Environ Toxicol Chem 30:354–359CrossRefGoogle Scholar
  53. Rendal C, Ole Kusk K, Trapp S (2011b) Optimal choice of pH for toxicity and bioaccumulation studies of ionizing organic chemicals. Environ Toxicol Chem 30:2395–2406CrossRefGoogle Scholar
  54. Shore RF, Taggart MA, Smits J, Mateo R, Richards NL, Fryday S (2014) Detection and drivers of exposure and effects of pharmaceuticals in higher vertebrates. Philos Trans R Soc Lond B Biol Sci 369:20130570CrossRefGoogle Scholar
  55. Skalar Analytical BV (2004) Skalar SanPlus analyzer general information, Breda, The NetherlandsGoogle Scholar
  56. Tappin AD, Loughnane JP, McCarthy AJ, Fitzsimons MF (2012) Removal of atrazine from river waters by indigenous microorganisms. Environ Chem Lett 10:89–96CrossRefGoogle Scholar
  57. Tappin AD, Loughnane JP, McCarthy AJ, Fitzsimons MF (2014) Bacterio-plankton transformation of diazepam and 2-amino-5-chlorobenzophenone in river waters. Environ Sci Process Impacts 16:2227–2236CrossRefGoogle Scholar
  58. Tijani JO, Fatoba OO, Babajide OO, Petrik LF (2016) Pharmaceuticals, endocrine disruptors, personal care products, nanomaterials and perfluorinated pollutants: a review. Environ Chem Lett 14:27–49CrossRefGoogle Scholar
  59. Uchida H, Suzuki T, Takeuchi H, Arenovich T, Mamo DC (2011) Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia: meta-analysis. Schizophr Bull 37:788–799CrossRefGoogle Scholar
  60. Villeneuve DL, Garcia-Reyero N, Martinovic D, Mueller ND, Cavallin JE, Durhan EJ, Makynen EA, Jensen KM, Kahl MD, Blake LS, Perkins EJ, Ankley GT (2010a) I. Effects of a dopamine receptor antagonist on fathead minnow, Pimephales promelas, reproduction. Ecotoxicol Environ Saf 73:472–477CrossRefGoogle Scholar
  61. Villeneuve DL, Garcia-Reyero N, Martinovic D, Mueller ND, Cavallin JE, Durhan EJ, Makynen EA, Jensen KM, Kahl MD, Blake LS, Perkins EJ, Ankley GT (2010b) II: effects of a dopamine receptor antagonist on fathead minnow dominance behavior and ovarian gene expression in the fathead minnow and zebrafish. Ecotoxicol Environ Saf 73:478–485CrossRefGoogle Scholar
  62. von der Ohe PC, Dulio V, Slobodnick J, de Deckere E, Kuhne R, Ebert RU, Ginebreda A, de Cooman W, Schuurmann G, Brack W (2011) A new risk assessment approach for the prioritization of 500 classical and emerging organic contaminants as potential river basin specific pollutants under the European Water Framework Directive. Sci Total Environ 409:2064–2077CrossRefGoogle Scholar
  63. Warhurst DC, Steele JCP, Adaga IS, Craig JC, Cullander C (2003) Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties. J Antimicrob Chemother 52:188–193CrossRefGoogle Scholar
  64. West CE, Rowland SJ (2012) Aqueous phototransformation of diazepam and related human metabolites under simulated sunlight. Environ Sci Technol 46:4749–4756CrossRefGoogle Scholar
  65. WHO (2015) Model list of essential medicines, 19th edn. http://www.who.int/medicines/publications/essentialmedicines/en/. Accessed 18 Jul 2016
  66. Wicker J, Lorsbach T, Gütlein M, Schmid E, Latino D, Kramer S, Fenner K (2016) enviPath—the environmental contaminant biotransformation pathway resource. Nucleic Acids Res 44:D502–D508CrossRefGoogle Scholar
  67. Yamamoto H, Nakamura Y, Moriguchi S, Nakamura Y, Honda Y, Tamura I, Hirata Y, Hayashi A, Sekizawa J (2009) Persistence and partitioning of eight selected pharmaceuticals in the aquatic environment: laboratory photolysis, biodegradation, and sorption experiments. Water Res 43:351–362CrossRefGoogle Scholar
  68. Zurita J, Jos A, del Peso A, Salguero M, López-Artíguez M, Repetto G (2005) Ecotoxicological evaluation of the antimalarial drug chloroquine. Aquat Toxicol 75:97–107CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Alan D. Tappin
    • 1
  • J. Paul Loughnane
    • 2
  • Alan J. McCarthy
    • 2
  • Mark F. Fitzsimons
    • 1
    Email author
  1. 1.School of Geography, Earth and Environmental SciencesPlymouth UniversityPlymouthUK
  2. 2.Microbiology Research Group, Institute of Integrative BiologyUniversity of LiverpoolLiverpoolUK

Personalised recommendations